Growth hormone (GH) and insulin-like growth factor
. Biotin-GH binding on CD20+ (Fig. 4) . There was no age-dependency for biotin-GH binding on CD20+ cells (Fig. 5) . mRNA expressions in lymphocytes and granulocytes from cord blood were equal to those from adult controls (Fig.  6) . Biotin-GH binding on CD20+ cells from patients with GH-deficiency, Turner syndrome, IDDM and CRF were similar to those of control subjects. (Fig. 7) . Previously, we (1, 5) . Our results conflicted with these data. It remains to be elucidated whether the regulatory role of GH in the immune system is mediated through its specific receptor or not.
There was no age-dependency of biotin-GH bindings on CD20+ lymphocytes, and there was no relationship between biotin-GH bindings on lymphocytes and serum GHBP activities. It has been suggested that GHBP is derived from extracellular components of tissue GH receptors, and its serum activities were correlated with tissue levels of GH receptor (6) . These results indicate that GHR on lymphocytes do not reflect the GH receptor dynamics in peripheral tissues. In contrast, Clot reported that a GH-dependent increment of pyruvate dehydrogenase activity in PBL was not observed in patients with Laron-type dwarfism, who have extreme resistance to GH due to GH receptor defect (7). Merimee reported that GH-stimulated IGF-I secretion by B lymphocytes from Pygmies, who are GHresistant, was lower than in controls (8) . These results suggest that the cellular response to GH can be used to investigate GH-resistance. The clinical significance of GHR on PBL requires further study.
There were IGF-IR on peripheral blood cells studied by flow cytometric analysis as described by Kooijman (9) . Furthermore, we detected IGF-IR protein on the blood cell surface using Western blotting and IGF-IR mRNA 
